Subcellular Distribution of Inorganic and Methylated Arsenic Compounds in Human Urothelial Cells and Human Hepatocytes

Epidemiological studies have indicated that exposure of humans to inorganic arsenic in drinking water is associated with the occurrence of bladder cancer. The mechanisms by which arsenic induces this malignancy are still uncertain; however, arsenic metabolites are suspected to play a pivotal role. The aim of the present study was the investigation of uptake capabilities of human urothelial cells (UROtsa) compared with primary human hepatocytes (phH) as well as the intracellular distribution of the arsenic species. Additionally, we were interested in the cyto- and genotoxic potential (comet assay, radical generation) of the different arsenic compounds in these two cell types. Our results show that UROtsa cells accumulate higher amounts of the arsenic species than the phH. Differential centrifugation revealed that the arsenic compounds are preferentially distributed into nuclei and ribosomes. After 24-h exposure, arsenic is mainly found in the ribosomes of UROtsa cells and in the nuclei and mitochondria of phH. In contrast to the pentavalent arsenic species, the trivalent species induced a 4- to 5-fold increase of DNA damage in hepatocytes. Radical generation, measured by thiobarbituric acid reactive substances, was more pronounced in hepatocytes than in urothelial cells. In summary, the uptake of arsenic compounds appears to be highly dependent upon cell type and arsenic species. The nonmethylating urothelial cells accumulate higher amounts of arsenic species than the methylating hepatocytes. However, cyto- and genotoxic effects are more distinct in hepatocytes. Further studies are needed to define the implications of the observed accumulation in cellular organelles for the carcinogenic activity of arsenic.

[1]  Sabina C. Grund,et al.  Arsenic and Arsenic Compounds , 2008 .

[2]  K. Kitchin,et al.  The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. , 2008, Journal of inorganic biochemistry.

[3]  T. Hei,et al.  Arsenic induced mitochondrial DNA damage and altered mitochondrial oxidative function: implications for genotoxic mechanisms in mammalian cells. , 2007, Cancer research.

[4]  C. Tseng,et al.  Arsenic Methylation, Urinary Arsenic Metabolites and Human Diseases: Current Perspective , 2007, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[5]  A. Kligerman,et al.  Oxidation and methylation status determine the effects of arsenic on the mitotic apparatus , 2005, Molecular and Cellular Biochemistry.

[6]  A. Hirner,et al.  Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  S. Waters,et al.  Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. , 2005, Toxicology and applied pharmacology.

[8]  Xiuwei Tang,et al.  Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells. , 2005, Cancer research.

[9]  S. Hirano,et al.  A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase Cyt19 , 2005, Archives of Toxicology.

[10]  A. Hirner,et al.  Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. , 2004, Toxicology and applied pharmacology.

[11]  S. Waters,et al.  Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. , 2004, Toxicology and applied pharmacology.

[12]  S. Waters,et al.  Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry , 2004 .

[13]  S. Okada,et al.  The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. , 2004, Toxicology and applied pharmacology.

[14]  L. Hudson,et al.  Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. , 2004, Chemical research in toxicology.

[15]  S. Waters,et al.  Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. , 2004, Chemical research in toxicology.

[16]  T. Rossman.  Mechanism of arsenic carcinogenesis: an integrated approach. , 2003, Mutation research.

[17]  A. Hartwig,et al.  Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. , 2003, DNA repair.

[18]  H. Aposhian,et al.  Oxidation and detoxification of trivalent arsenic species. , 2003, Toxicology and applied pharmacology.

[19]  A. Hartwig,et al.  Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. , 2003, Carcinogenesis.

[20]  M. Tam,et al.  Identification of galectin I and thioredoxin peroxidase II as two arsenic-binding proteins in Chinese hamster ovary cells. , 2003, The Biochemical journal.

[21]  K. Kitchin,et al.  Oxidative stress as a possible mode of action for arsenic carcinogenesis. , 2003, Toxicology letters.

[22]  M. Schuliga,et al.  Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  R. Scherer,et al.  Influence of nutrient intake on blood lead levels of young children at risk for lead poisoning. , 2002, Environmental health perspectives.

[24]  S. Nesnow,et al.  DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. , 2002, Chemical research in toxicology.

[25]  I. Jaspers,et al.  The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. , 2002, Environmental health perspectives.

[26]  W. Cullen,et al.  Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. , 2002, Toxicology letters.

[27]  Michael F Hughes,et al.  Arsenic toxicity and potential mechanisms of action. , 2002, Toxicology letters.

[28]  J. B. Simeonsson,et al.  A NovelS-Adenosyl-l-methionine:Arsenic(III) Methyltransferase from Rat Liver Cytosol* , 2002, The Journal of Biological Chemistry.

[29]  X. Le,et al.  Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid , 2001 .

[30]  S. Garrett,et al.  The immortalized UROtsa cell line as a potential cell culture model of human urothelium. , 2001, Environmental health perspectives.

[31]  K. Kitchin.  Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. , 2001, Toxicology and applied pharmacology.

[32]  A. Giri,et al.  Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. , 2001, Mutation research.

[33]  E. Kenyon,et al.  A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. , 2001, Toxicology.

[34]  W. Cullen,et al.  Methylated trivalent arsenic species are genotoxic. , 2001, Chemical research in toxicology.

[35]  S. X. Liu,et al.  Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Cullen,et al.  Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells , 2000, Archives of Toxicology.

[37]  H. Aposhian,et al.  Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. , 1999, Chemical research in toxicology.

[38]  W. Cullen,et al.  Metabolism of arsenic in primary cultures of human and rat hepatocytes. , 1999, Chemical research in toxicology.

[39]  M. Stýblo,et al.  Binding of arsenicals to proteins in an in vitro methylation system. , 1997, Toxicology and applied pharmacology.

[40]  W. Cullen,et al.  Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. , 1997, Chemical research in toxicology.

[41]  X. Le,et al.  Speciation of Arsenic Compounds Using High-Performance Liquid Chromatography at Elevated Temperature and Selective Hydride Generation Atomic Fluorescence Detection , 1996 .

[42]  J. Haines,et al.  International programme on chemical safety , 1996, The Lancet.

[43]  Y. Hsueh,et al.  Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. , 1995, Cancer research.

[44]  A. Nussler,et al.  A New Technique for Isolating and Culturing Human Hepatocytes from Whole or Split Livers not Used for Transplantation , 1994, Cell transplantation.

[45]  A. Nussler,et al.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin , 1992, The Journal of experimental medicine.

[46]  H. Yamauchi,et al.  [Effect of S-adenosylmethionine on methylation of inorganic arsenic]. , 1990, Nihon eiseigaku zasshi. Japanese journal of hygiene.

[47]  J. Calvet,et al.  The heat shock response in HeLa cells is accompanied by elevated expression of the c-fos proto-oncogene , 1987, Molecular and cellular biology.

[48]  H. Kay.  Environmental Health Criteria , 1980 .

[49]  H. Aposhian,et al.  Arsenic toxicology: five questions. , 2006, Chemical research in toxicology.

[50]  T. Hei,et al.  Arsenic induces oxidative DNA damage in mammalian cells , 2004, Molecular and Cellular Biochemistry.

[51]  D. DeMarini,et al.  Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations , 2003, Environmental and molecular mutagenesis.

[52]  T. Gebel,et al.  Genotoxicity of arsenical compounds. , 2001, International journal of hygiene and environmental health.

[53]  D. E. Carter,et al.  Reactions of arsenic(III) and arsenic(V) species with glutathione. , 1993, Chemical research in toxicology.

[54]  P. Gomez-Caminero,et al.  Arsenic and arsenic compounds. , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[55]  F. Challenger.  Biological methylation. , 1951, Advances in enzymology and related subjects of biochemistry.